The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Portrait of Ana Nordberg. Photo.

Ana Nordberg

Senior lecturer

Portrait of Ana Nordberg. Photo.

Rules and Tools in the Battle against Superbugs - A call for integrated strategies and enhanced international collaboration to promote antimicrobial drug development

Author

  • Timo Minssen
  • Ana Nordberg

Editor

  • Mark Eccleston-Turner
  • Iain Brassington

Summary, in English

The lack of treatments during the recent Ebola and Zika outbreaks dramatically exposed the vulnerability of the global health system and the dire consequences thereof. But even where therapies against infectious diseases had been available, an additional threat has gained world-wide attention: antimicrobial resistance (AMR). A growing number of microbial organisms are becoming resistant to available drugs with increasingly diverse risks for a rapid global spreading of infections. Unfortunately, the traditional IP based innovation system and regulatory frameworks do not provide sufficient incentives to invest in the development of new antimicrobials. Hence, there are few new treatments in the pipeline to replace a growing number of ineffective drugs or problematic drug combinations. Repairing these broken economic incentives, improving access to and sustaining the effectiveness of antimicrobials is among the most important challenges in the health and life sciences. In this paper we emphasize that this goal can only be achieved through integrated strategies and a better global coordination of interdisciplinary multi-sector responses.

Department/s

  • Human Rights Law
  • Health Law
  • Lund University Centre for Business Law (Swedish abbr: ACLU)
  • Department of Law

Publishing year

2020-05-16

Language

English

Pages

111-136

Publication/Series

Infectious Diseases in the New Millennium: Legal and Ethical Challenges

Document type

Book chapter

Publisher

Springer

Topic

  • Law

Keywords

  • Private law
  • Regulatory pathways
  • Accelerators
  • IPRs
  • Antimicrobials
  • Resistance
  • Sustainable incentives
  • Civilrätt

Status

Published

Research group

  • Human Rights Law
  • Health Law
  • Lund University Centre for Business Law (Swedish abbr: ACLU)

ISBN/ISSN/Other

  • ISBN: 978-3-030-39819-4
  • ISBN: 978-3-030-39818-7